In conclusion, combining the gastroscopy, MSCT, immunohistochemical marker HER-2, serum tumor marker CEA, CA242, CA724, and CA199 can improve the sensitivity of early diagnosis for gastric cancer, showing a sensitivity of 86.73%, and significantly better than that of each single detection (P < 0.05). Here, ERBB2 is linked to gastric cancer.